<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Metoclopramide</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01233</strong>&#160; (APRD00665)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved, investigational</td></tr><tr><th>Description</th><td><p>A dopamine D2 antagonist that is used as an antiemetic. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01233/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01233/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01233.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01233.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01233.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01233.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01233.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01233">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>2-methoxy-5-chloroprocainamide</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Metoclopramida</td><td>Spanish</td><td>INN</td></tr><tr><td>Metoclopramidum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>Metoclopramide Hydrochloride</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT000393/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT000393/thumb.png"></a></td>
        <td>
            <ul>
              <li>InChI Key: KJBLQGHJOCAOJP-UHFFFAOYSA-N</li>
              <li>Monoisotopic Mass: 353.127297095</li>
              <li>Average Mass: 354.273</li>
            </ul>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT000393">DBSALT000393</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Cerucal</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Degan</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Elieten</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Maxeran</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Maxolon</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>METOZOLV</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Plasil1</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Plazilin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Pramin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Primperan</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Pulin</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Pylomid</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Reglan</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Reliveran</td><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/antiemetics">Antiemetics</a></li>
<li><a href="/mesh/dopamine-antagonists">Dopamine Antagonists</a></li>
<li><a href="/mesh/prokinetic-agents">Prokinetic Agents</a></li></ul></td></tr><tr><th>CAS number</th><td>364-62-5</td></tr><tr><th>Weight</th><td>Average: 299.796<br>Monoisotopic: 299.14005467</td></tr><tr><th>Chemical Formula</th><td>C<sub>14</sub>H<sub>22</sub>ClN<sub>3</sub>O<sub>2</sub></td></tr><tr><th>InChI Key</th><td>TTWJBBZEZQICBI-UHFFFAOYSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Benzenoids</td></tr><tr><th>Class</th><td>Benzene and Substituted Derivatives</td></tr><tr><th>Subclass</th><td>Benzoic Acid and Derivatives</td></tr><tr><th>Direct parent</th><td>Salicylamides</td></tr><tr><th>Alternative parents</th><td>Aminobenzamides; Benzoyl Derivatives; Anisoles; Anilines; Alkyl Aryl Ethers; Chlorobenzenes; Aryl Chlorides; Primary Aromatic Amines; Tertiary Amines; Secondary Carboxylic Acid Amides; Polyamines; Enolates; Carboxylic Acids; Organochlorides</td></tr><tr><th>Substituents</th><td>benzoyl; phenol ether; anisole; alkyl aryl ether; aniline; chlorobenzene; aryl chloride; aryl halide; primary aromatic amine; carboxamide group; secondary carboxylic acid amide; tertiary amine; ether; polyamine; carboxylic acid; carboxylic acid derivative; enolate; organochloride; organohalogen; amine; primary amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the salicylamides. These are carboxamide derivatives of salicylic acid.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of gastroesophageal reflux disease (GERD). It is also used in treating nausea and vomiting, and to increase gastric emptying.</td></tr><tr><th>Pharmacodynamics</th><td>Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.</td></tr><tr><th>Mechanism of action</th><td>Metoclopramide inhibits gastric smooth muscle relaxation produced by dopamine, therefore increasing cholinergic response of the gastrointestinal smooth muscle. It accelerates intestinal transit and gastric emptying by preventing relaxation of gastric body and increasing the phasic activity of antrum. Simultaneously, this action is accompanied by relaxation of the upper small intestine, resulting in an improved coordination between the body and antrum of the stomach and the upper small intestine. Metoclopramide also decreases reflux into the esophagus by increasing the resting pressure of the lower esophageal sphincter and improves acid clearance from the esophagus by increasing amplitude of esophageal peristaltic contractions. Metoclopramide's dopamine antagonist action raises the threshold of activity in the chemoreceptor trigger zone and decreases the input from afferent visceral nerves. Studies have also shown that high doses of metoclopramide can antagonize 5-hydroxytryptamine (5-HT) receptors in the peripheral nervous system in animals.</td></tr><tr><th>Absorption</th><td>Rapidly and well absorbed (oral bioavailability 80&#177;15.5%).</td></tr><tr><th>Volume of distribution</th><td><ul>
	<li>4.4&#177;0.65 L/kg</li>
</ul></td></tr><tr><th>Protein binding</th><td>30%</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>Hepatic</p></td></tr><tr><th>Route of elimination</th><td>Approximately 85% of the radioactivity of an orally administered dose appears in the urine within 72 hours.</td></tr><tr><th>Half life</th><td>5-6 hr</td></tr><tr><th>Clearance</th><td><ul>
	<li>0.67 +/- 0.14 L/hr/kg [infants (0.9-5.4 months) with gastroesophageal reflux (<span class="caps">GER</span>)]</li>
</ul></td></tr><tr><th>Toxicity</th><td>Oral, mouse LD<sub>50</sub>: 280 mg/kg. Signs of overdose include drowsiness, disorientation, and extrapyramidal reactions.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              +
        </td>
        <td>0.979</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.9713</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.8866</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.7687</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8782</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8783</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.7276</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8602</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Substrate</td>
        <td>0.8918</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Substrate</td>
        <td>0.6375</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Inhibitor</td>
        <td>0.9107</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9071</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Inhibitor</td>
        <td>0.8931</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9025</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9099</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.6223</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.5378
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.6142
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            1.0
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.6332 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.8367
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Inhibitor 
        </td>
        <td>
            0.8579
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Roxane laboratories inc</li>
<li>Abraxis pharmaceutical products</li>
<li>Bedford laboratories div ben venue laboratories inc</li>
<li>Hospira inc</li>
<li>Norbrook laboratories ltd</li>
<li>Smith and nephew solopak div smith and nephew</li>
<li>Teva parenteral medicines inc</li>
<li>Baxter healthcare corp anesthesia critical care</li>
<li>Actavis mid atlantic llc</li>
<li>Ani pharmaceuticals inc</li>
<li>Morton grove pharmaceuticals inc</li>
<li>Paco research corp</li>
<li>Pharmaceutical assoc inc div beach products</li>
<li>Silarx pharmaceuticals inc</li>
<li>Teva pharmaceuticals usa inc</li>
<li>Vistapharm inc</li>
<li>Wockhardt eu operations (swiss) ag</li>
<li>Ah robins co</li>
<li>Salix pharmaceuticals inc</li>
<li>Alaven pharmaceutical llc</li>
<li>Quantum pharmics ltd</li>
<li>King pharmaceuticals inc</li>
<li>Actavis elizabeth llc</li>
<li>Clonmel healthcare ltd</li>
<li>Halsey drug co inc</li>
<li>Interpharm inc</li>
<li>Ipca laboratories ltd</li>
<li>Mutual pharmaceutical co inc</li>
<li>Northstar healthcare holdings ltd</li>
<li>Par pharmaceutical inc</li>
<li>Sandoz inc</li>
<li>Schering corp sub schering plough corp</li>
<li>Superpharm corp</li>
<li>Usl pharma inc</li>
<li>Vintage pharmaceuticals inc</li>
<li>Watson laboratories inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.actavis.com">Actavis Group</a></li>
<li>Advanced Pharmaceutical Services Inc.</li>
<li><a href="http://www.alavenpharm.com">Alaven Pharmaceutical</a></li>
<li>Almus Pharmaceuticals Usa LLC</li>
<li><a href="http://www.amerisourcebergen.com">Amerisource Health Services Corp.</a></li>
<li>Anip Acquisition Co.</li>
<li><a href="http://orders.a-smeds.com">A-S Medication Solutions LLC</a></li>
<li><a href="http://www.atlanticbiologicals.com">Atlantic Biologicals Corporation</a></li>
<li><a href="http://www.baxter.com">Baxter International Inc.</a></li>
<li>Bay Pharma Inc.</li>
<li><a href="http://bryantranchprepack.com">Bryant Ranch Prepack</a></li>
<li><a href="http://www.cardinal.com">Cardinal Health</a></li>
<li>Comprehensive Consultant Services Inc.</li>
<li>Dept Health Central Pharmacy</li>
<li>Direct Dispensing Inc.</li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dhscorp.com">Diversified Healthcare Services Inc.</a></li>
<li><a href="http://www.duramed.ca">Duramed</a></li>
<li><a href="http://www.giv.com">General Injectables and Vaccines Inc.</a></li>
<li><a href="http://hjharkinscompanyinc.com">H.J. Harkins Co. Inc.</a></li>
<li>Heartland Repack Services LLC</li>
<li><a href="http://www.hospira.com">Hospira Inc.</a></li>
<li><a href="http://www.innoviantpharmacy.com">Innoviant Pharmacy Inc.</a></li>
<li><a href="http://www.ipcalabs.com">Ipca Laboratories Ltd.</a></li>
<li>Lake Erie Medical and Surgical Supply</li>
<li>Liberty Pharmaceuticals</li>
<li><a href="http://www.majorpharmaceuticals.com">Major Pharmaceuticals</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.medisca.com">Medisca Inc.</a></li>
<li><a href="http://www.unitdosesupply.com">Murfreesboro Pharmaceutical Nursing Supply</a></li>
<li>Mutual Pharmaceutical Co.</li>
<li>Neighborcare Repackaging Inc.</li>
<li>Neuman Distributors Inc.</li>
<li>Northstar Rx LLC</li>
<li><a href="http://www.nucarerx.com">Nucare Pharmaceuticals Inc.</a></li>
<li><a href="http://www.palmettopharm.com">Palmetto Pharmaceuticals Inc.</a></li>
<li>PCA LLC</li>
<li>Pharmaceutical Association</li>
<li>Pharmaceutical Packaging Center</li>
<li>Pharmaceutical Utilization Management Program VA Inc.</li>
<li><a href="http://www.pharmedixrx.com">Pharmedix</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.piramalpharmasolutions.com">Piramal Healthcare</a></li>
<li><a href="http://www.pliva.com">Pliva Inc.</a></li>
<li><a href="http://www.precisiondose.com">Precision Dose Inc.</a></li>
<li><a href="http://www.preferredpharmaceuticals.com">Preferred Pharmaceuticals Inc.</a></li>
<li><a href="http://www.prepaksys.com">Prepak Systems Inc.</a></li>
<li><a href="http://www.worldoftest.com">Qualitest</a></li>
<li><a href="http://www.ranbaxy.com">Ranbaxy Laboratories</a></li>
<li><a href="http://www.rebelrx.com">Rebel Distributors Corp.</a></li>
<li>Redpharm Drug</li>
<li><a href="http://www.remedyrepack.com">Remedy Repack</a></li>
<li><a href="http://www.salix.com">Salix Pharmaceuticals</a></li>
<li><a href="http://www.sandhillspackaging.com">Sandhills Packaging Inc.</a></li>
<li><a href="http://www.sandoz.ca">Sandoz</a></li>
<li><a href="http://www.silarx.com">Silarx Pharmaceuticals</a></li>
<li><a href="http://www.southwoodhealthcare.com">Southwood Pharmaceuticals</a></li>
<li><a href="http://www.tevapharm.com">Teva Pharmaceutical Industries Ltd.</a></li>
<li>Tya Pharmaceuticals</li>
<li><a href="http://www.udllabs.com">UDL Laboratories</a></li>
<li>Vangard Labs Inc.</li>
<li><a href="http://www.viasyshealthcare.com">Viasys Medsystems</a></li>
<li>Vintage Pharmaceuticals Inc.</li>
<li><a href="http://www.vistapharm.com">Vistapharm Inc.</a></li>
<li><a href="http://www.watson.com">Watson Pharmaceuticals</a></li>
<li><a href="http://www.wockhardtin.com">Wockhardt Ltd.</a></li>
<li>Xactdose Inc.</li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Liquid</td><td>Intramuscular</td><td></td></tr><tr><td>Liquid</td><td>Intravenous</td><td></td></tr><tr><td>Liquid</td><td>Oral</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00091">Cyclosporine</a></td><td>Metoclopramide increases serum levels of cyclosporine</td></tr><tr><td><a href="/drugs/DB01235">L-DOPA</a></td><td>Levodopa decreases the effect of metoclopramide</td></tr><tr><td><a href="/drugs/DB08815">Lurasidone</a></td><td>Increases toxicity and risk of extrapyramidal effects of lurasidone by antidopaminergic effects. Concomitant therapy should be avoided.</td></tr><tr><td><a href="/drugs/DB01267">Paliperidone</a></td><td>Metoclopramide may increase the risk of extrapyramidal side effects of paliperidone. Concomitant therapy should be avoided. </td></tr><tr><td><a href="/drugs/DB00864">Tacrolimus</a></td><td>Metoclopramide may increase the concentration of Tacrolimus in the blood. Monitor for changes in the therapeutic/toxic effects of Tacrolimus if Metoclopramide therapy is initiated, discontinued or altered.</td></tr><tr><td><a href="/drugs/DB04844">Tetrabenazine</a></td><td>Similar pharmacologic properties thus combination therapy will worsen the severity of sedative, parkinsonian, and extrapyramidal adverse effects. </td></tr><tr><td><a href="/drugs/DB00285">Venlafaxine</a></td><td>Possible serotoninergic syndrome with this combination</td></tr><tr><td><a href="/drugs/DB06684">Vilazodone</a></td><td>Seek alternatives to this combination when possible. Monitor patients receiving metoclopramide with selective serotonin reuptake inhibitors for signs of extrapyramidal symptoms, neuroleptic malignant syndrome, and serotonin syndrome. </td></tr><tr><td><a href="/drugs/DB01624">Zuclopenthixol</a></td><td>Additive dopamine D2 receptor antagonism may cause dopaminergic imbalance in the nigrostriatal (dopamine D1 receptors) and striatopallidal (dopamine D2 receptors). Increased risk of extrapyramidal reactions and neuroleptic malignant syndrome. Concomitant therapy should be avoided. </td></tr><tr><td><a href="/drugs/DB08919">Zuclopenthixol acetate</a></td><td>Additive dopamine D2 receptor antagonism may cause dopaminergic imbalance in the nigrostriatal (dopamine D1 receptors) and striatopallidal (dopamine D2 receptors). Increased risk of extrapyramidal reactions and neuroleptic malignant syndrome. Concomitant therapy should be avoided. </td></tr><tr><td><a href="/drugs/DB08920">Zuclopenthixol decanoate</a></td><td>Additive dopamine D2 receptor antagonism may cause dopaminergic imbalance in the nigrostriatal (dopamine D1 receptors) and striatopallidal (dopamine D2 receptors). Increased risk of extrapyramidal reactions and neuroleptic malignant syndrome. Concomitant therapy should be avoided. </td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><ul><li>Food reduces availability, take 30 minutes before meals. Avoid alcohol.</li></ul></td></tr></tbody></table>